Vyripharm is committed to innovations helping people live better lives. Learn more about Novel Integrated Theranostic Approach for the Treatment of Viral Infections like COVID-19 press releaseRead the Press Release
"Personalized Medicine"- providing patients with the right drug, at the right dose, at the right time
Drug processing and development from "bench to bedside"
Maintaining GLP/GMP regulatory standards for synthetic pharmaceuticals and natural pharmaceuticals (botanicals)
QA/QC is Vyripharm's focus for enhancing public safety, public health and public awareness
To deliver a drug dose in the right amount at the right time and with better efficacy
QC data with IT integration
Targeted treatment of debilitating diseases such PTSD. Vyripharm’s translational research platform targets chronic disease states.
Pharmaceuticals and Radiopharmaceuticals. Vyripharm develops novel platforms for molecular imaging and therapy.
Chronic Pain. Vyripharm’s translational drug delivery platforms should reduce the 1.5 billion people suffering with chronic pain worldwide.